Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age

NCT07823595 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
90
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer